HARVARD BIOSCIENCE INC 8-K

What Happened

• On March 12, 2026, Harvard Bioscience, Inc. announced financial results for the three and twelve months ended December 31, 2025 and scheduled a related conference call for 8:00 AM ET on March 12, 2026.
• The company furnished the press release announcing those results as Exhibit 99.1 to the Form 8‑K filed the same day; the 8‑K itself references the press release for the detailed numbers.

Key Details

• Filing date: March 12, 2026 (Form 8‑K, Item 2.02).
• Period covered: Three and twelve months ended December 31, 2025 (quarterly and full‑year results).
• Conference call: Scheduled for March 12, 2026 at 8:00 AM ET to discuss the results.
• Exhibits: Press release furnished as Exhibit 99.1 (and XBRL cover page as Exhibit 104).

Why It Matters

• Earnings releases and the accompanying conference call provide updated information on revenue, profit/loss, and management commentary—data that can affect the company’s stock price and investor decisions.
• Retail investors should review the press release (Exhibit 99.1) and listen to or read the call transcript for details on quarterly results, trends, and any forward guidance from management.